Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
Explore this paper's citation graph
Summary
Treatment of etiology, by ameliorating cyanoacrylate injection and endovascular approach, target the mechanical component of the increased intrahepatic resistance, which leads to a hyperdynamic circulatory state that further increases portal venous inflow and PP.
- Type
- article
- Published
- 2017-01-01
- Cited by
- 1,992
- References
- 154
- OpenAlex
- https://openalex.org/W2546046192
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:963110
Keywords
Cirrhosis, Risk stratification, Medicine, Portal hypertension, Internal medicine
References
- Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis
- Early use of TIPS in patients with cirrhosis and variceal bleeding.
- Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.
- Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis.
- Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.
- Liver stiffness plus platelet count can be used to exclude high‐risk oesophageal varices
- Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
- Meta‐analysis: isosorbide‐mononitrate alone or with either beta‐blockers or endoscopic therapy for the management of oesophageal varices
- Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.
- Meta‐analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding – an updated Cochrane review
- A randomized trial of endoscopic variceal ligation versus cyanoacrylate injection for treatment of bleeding junctional varices.
- Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.
- Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.
- Statins are Associated with a Decreased Risk of Decompensation and Death in Veterans with Hepatitis C-related Compensated Cirrhosis
- Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding
- Vascular Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Gastric Varices and Hepatic Encephalopathy: A Prospective Multicenter Study.
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Non-alcoholic Fatty Liver Disease: A Diagnostic Accuracy Systematic Review and Individual Participant Data Pooled Analysis
- Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension.
- Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results
- Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
Cited by
- The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
- Acute Liver Injury and Decompensated Cirrhosis.
- Myosteatosis is an independent risk factor for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunting
- The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
- Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
- Management of portal hypertension, Budd–Chiari syndrome and portal vein thrombosis
- Assessment and Management of Portal Hypertensive Bleeding in Cirrhosis
- PORTAL HYPERTENSION AND VARICES: PATHOGENESIS, STAGES, AND MANAGEMENT
- REPLY TO HEP-16-2222
- Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis
- Non-invasive evaluation of portal hypertension using ultrasound elastography.
- Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors.
- The epidemiology and pathogenesis of gastrointestinal varices
- Primary and secondary prophylaxis of esophageal variceal bleeding
- Endoscopic Ultrasound-Guided Vascular Therapy: The Present and the Future
- Therapeutic evaluation of arterio-portal fistula-related gastroesophageal variceal bleeding
- Reply to: Does the dose and type of NSBBs really matter?
- Does the dose and type of nonselective beta‐blocker really matter?
- Recent advances in the management of variceal bleeding
- Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis
Related papers
- Analysis on Clinical Characteristics of Primary Hepatocellular Carcinoma with or Without Cirrhosis
- Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.
- Management of Portal Hypertension.
- The Relationship between Serum Nitric Oxide and Hypoxemia of Liver Cirrhosis
- Blood and plasma 5‐hydroxytryptamine levels in patients with cirrhosis
- Clinical analysis of 6 cases of idiopathic portal hypertension misdiagnosed as cirrhosis
- Portal hypertension of cirrhosis and its complications